A medical communications agency, by the numbers
We have some of the brightest minds in oncology and hematology medical communications. Our global resources, strategic programs, and longstanding relationships with key scientific leaders provide our life science partners with future-focused, evidence-based solutions – all designed to improve clinical decision making and enhance patient outcomes. View our Facts & Figures Infographic.
The power of evidence-based, omnichannel innovation
Helping our partners successfully navigate the complex oncology and hematology marketplace is a critical part of what we do best. That’s why we created D3 – our unique, 3-phase approach provides competitive solutions to your most difficult challenges, every time.
Better decisions start with strategic expertise
We partner with the world’s best
Up-to-date stories, articles, and insights from the TRM Oncology team
For pharma, an oncology conference is an important opportunity to inform and engage healthcare providers on the newest knowledge, with the motivation to improve patient outcomes and improve adherence.
Changes to patient-centric care require first and foremost the participation of healthcare professionals (HCPs), who have a huge impact on quality health practices.
As one of the highest priorities of pharma marketers, engaging with industry leaders is a crucial strategic exercise. Findings from an online survey in 2015 revealed that 62% of medical experts believe that the term “KOL” should be replaced. Yet coming up with an alternative is a challenge.
Get the latest insights on medical communications and the pharma industry.